http://doi.org/10.31288/oftalmolzh201865258

Received: 09 October  2018; Published on-line: 31 December 2018

Soft-tissue response to synthetic polymer implants made of cross-linked polyurethane and containing a biologically active substance, albucid or dacarbazine, in animals

N.A. Galatenko,1 Dr Sc (Chem); D.V. Kulyesh,1 Cand Sc (Chem); A.P. Maletskyi, 2 Dr Sc (Med); O.S. Karpenko, 1 Cand Sc (Chem)

1  Institute for Chemistry of High-Molecular Compounds of the NAS of Ukraine;  Kyiv (Ukraine) 

2 Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine; Odessa (Ukraine)

E-mail: maletskiy@filatov.com.ua

TO CITE THIS ARTICLE: Galatenko NA, Kulyesh DV, Maletskyi AP, Karpenko OS. Soft-tissue response to synthetic polymer implants made of cross-linked polyurethane and containing a biologically active substance, albucid or dacarbazine, in animals. J.ophthalmol.(Ukraine).2018;6:52-58. http://doi.org/10.31288/oftalmolzh201865258

 

Background: It is an urgent task of the today’s science to search for and introduce biointegrable synthetic materials into medical practice.

Purpose: To investigate the soft tissue response to the polymer sample implants made of cross-linked polyurethane with an immobilized biologically active substance, albucid or dacarbazine, in animals.

Materials and Methods: Thirty Wistar rats were used to assess the soft tissue response to polymer sample implants under examination. The cross-linked polyurethane-based sample implants with an immobilized biologically active substance, albucid or dacarbazine, were used in the experimental study.

Results: The development of the connective tissue capsule around the sample implant, with the capsule completely separating the implant from the surrounding host tissue, was observed at the early time points. Sample implant porosity contributed to cell migration and gradual ingrowth of tissue structures into the implants, which prevented fast implant resorption, and was indicative of the implant biocompatibility with the host tissues. The placement of albucid-containing polyurethane implants in experimental animals resulted in the surrounding host tissue responses typical of aseptic inflammation. The placement of the dacarbazine-containing polyurethane implant in the back of each animal resulted in apparent changes in surrounding host tissue typical for the inflammatory process. It is likely that dacarbazine from the dacarbazine-containing polyurethane sample implant was durably released in the host tissues surrounding the sample, and exerted some biologically active effect which resulted in persistent inflammation at the site of implantation.

Conclusion: The albucid- and dacarbazine-containing polymer materials obtained seem promising, and might be widely used as soft tissue substitutes in restorative and reconstructive eye and maxillofacial surgery.

Keywords: implant placement, polyurethane, biological activity, soft tissue response, experiment

 

References

1.Krasnovid TA. [Ocular trauma under present conditions.  Providing urgent care in Ukraine]. Proceedings of the Conference of Ophthalmologists of Chernihiv, Kyiv, and other regions. Chernihiv; 2013. pp. 40-4. Russian.

2.Tselomudryi AI, Venger GE, Pogorelyi DN, Rizvaniuk AV. [Current system of stage-by-stage treatment for combat-related eye injuries in the area of ATO]. Visnyk morskoi meditsyny. 2016;2(71):196-203. Russian.

3.Hintschich C. [Dermis-fat graft. Possibilities and limitations]. Ophthalmologe. 2003 Jul;100(7):518-24.
Crossref   Pubmed

4.Danz W Sr. Mobility implants: a review. Adv Ophthalm Plast Reconstr Surg. 1990;8:46-52.

5.Karaian AS. [One-stage repair of traumatic defects and deformations of the chhekbone, nose, and orbit complex].  [Dr Sc (Med) Dissertation]. Moscow: Central Research Institute for Dentistry and Maxillofacial Surgery; 2015. Russian.

6.Kugoeva EE. [Diagnosis and management of injuries and diseases of the eyelid and orbit as those of the adnexal structures]. [Dr Sc (Med) Dissertation]. Moscow: Research Institute of Eye Diseases; 1997. Russian.

7.Gorbunova ED. [Clinical picture, diagnosis and treatment of orbital wall fractures in children]. [Cand Sc (Med) Thesis]. Moscow: Research Institute of Eye Diseases; 2006. Russian.

8.Constantian MB. Use of auricular cartilage in orbital floor reconstruction. Plast Reconstr Surg. 1982 Jun;69(6):951-5.
Crossref   Pubmed

9.Adenis P. [Secondary reconstruction of anophthalmic orbits by intraorbital biomaterial implantation]. J Fr Ophtalmol. 1999 Mar;22(2):269-73. French.

10.Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. Plast Reconstr Surg. 1979 May;63(5):626-33.
Crossref   Pubmed

11.Grusha IaO, Fedorov AA, Dzemeshkevich VV, Blinova IV. [The clinical-and-morphological specificity of using xenopericardium in plasty of the eyelid and orbit]. Vestn Oftalmol. 2004 Sep-Oct;120(5):19-21. Russian.

12.Froddel J, Seung L. The use of high-density polyethylene implants in facial deformities. Arch Otolaryngol Head and Neck Surg. 1998 Nov;124(11):1219-23.
Crossref   Pubmed

13.Gundorova RA, Bykov VP, Verigo EN, et al. [On the use of carbon implants in ocular plastic surgery]. Oftalmol Zh. 1996;2:77-9. Russian.

14.Astakhov YuS, Nikolaenko VP, D’yakov VE. [Use of polytetrafluoroethylene implants  in ophthalmic surgery]. St Petersburg: Foliant; 2007. Russian.

15.Davydov DV. [Medical and biological aspects of the comprehensive use of biological materials in patients with anophthalmos]. [Abstract of Dr Sc (Med) Dissertation]. Moscow: Research Institute of Eye Diseases; 2000. Russian.

16.Krasilnikova VL. [Foamed ceramics- and l hydroxyapatite-based ocomotor stump of the ocular prosthesis (experimental study)]. [Cand Sc (Med) Thesis]. St Petersburg: Russian Medical Academy of Postgraduate Education; 2002. Russian.

17.Sisler HA, Walsh JB, Finlay JR. Implant with postoperative drain after evisceration. Am J Ophthalmol. 1973 Oct;76(4):537-9.

18.Ferrone PI, Dutton JJ. Rate of vascularization of coralline hydroxyapatite ocular implants. Ophthalmology. 1992 Mar;99(3):376-9.

19.Roze GE. The volume-deficient orbit: Clinical characteristics, surgical management and results after extraperiorbital implantation of Silastic block. Brit J Ophthal. 1990 Sep;74(9):545-50.

20.Kanyukov VN., Stadnikov AA, Trubina OO. [Plastic material for ophthalmic surgery]. Proceedings of the 4th Ophthalmology Conference. Kyiv; 1998: 171-2. Russian.

21.Shatilova TA, Dumbadze GG, Mikadzhe GS, Onikani OV. [Alumina ceramics-based ocular implant]. In: [Plastic surgery of orbit and eye prosthetics]. Collection of scientific works. Moscow; 1981. p. 68-9. Russian.

22.Filatov LN. [The use of Teflon insert and homosclera as implants to form a locomotor stump after evisceration of the eye]. In: [Plastic surgery of orbit and eye prosthetics]. Collection of scientific works. Moscow; 1981. p. 63-5. Russian.

23.Tabatabaee Z, Mazloumi M, Rajabi MT, et al. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients. Ophthal Plast Reconstr Surg. 2011 Mar-Apr;27(2):114-8. doi: 10.1097/IOP.0b013e3181e9790d.

24.Chao DL, Harbour JW. Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma. Can J Ophthalmol. 2015;50:151-4.

25.Galatenko NA, Rozhnova RA. [Biologically active polymeric materials for medicine]. Kyiv: Naukova Dumka; 2013. Russian.

26.Galatenko NA., Rozhnova RA, Kebuladze IM, et al. [Study of the biocompatibility of linear polyurethanes for endoprosthetics]. Reports of the National Academy of Sciences of Ukraine. 2002;1: 131-5. Russian.

27.Galatenko NA. [Influence of biologically active polyurethane implants on the processes of reparative regeneration and tissue differentiation]. [Cand Sc (Med) Thesis]. Kyiv; 1997. Ukrainian.

28.Kulyesh DV, Nechaeva LIu, Karpik EN, Grytsenko VP, Galatenko NA, Kebuladze IM. [Study of biocompatibility and bioactivity of polyurethane implantable material with immobilized methyluracil]. Plastychna ta rekonstruktyvna khirurgiia. 2014;3-4:49-58. Ukrainian.

29.Galatenko NA, Rozhnova RA. [Investigation of the influence of prolonged form of amison in the cross-linked polyurethane on the course of processes of reparative regeneration]. Visnyk morphologii. 2009;2: 320-5. Ukrainian.

30.Rozhnova RA, Galatenko NA, Narazhaiko LF. [Study of biodegradation and biocompatibility of lactose-containing polyurethane elastomers]. Reports of the National Academy of Sciences of Ukraine. 2006;2:155-61. Ukrainian.

31.Rozhnova RA, Galatenko NA, Savitskaya OS, et al. [Investigation of the effectiveness of polymeric pharmaceutical forms of NSAIDs based on segmented polyurethane elastomers in vivo]. Polimernyi Zhurnal. 2008;30(3):256-61. Ukrainian.

32.Rozhnova RA, Shilov VV, Galatenko NA. [Structural and morphological studies of biologically active implants with prolonged healing action]. Kompozitsiini polymerni materialy. 2000;22 (2): 146-50. Russian.

33.European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Council of Europe, Strasbourg; 1986.

34.Sarkisov DS, Petrova YuL. [Microscopic technique]. Moscow: Meditsina; 1996. Russian.